Abstract:Abnormal neuronal morphological features, such as dendrite branching, axonal branching, and spine density, is thought to contribute to the symptoms of depression and anxiety. However, the role and molecular mechanisms of aberrant neuronal morphology in the regulation of mood disorders remain poorly characterized. Here, we show that Neuritin, an activity-dependent protein, regulates the axonal morphology of serotonin neurons. Male neuritin knockout mice harbored impaired axonal branches of serotonin neurons in the medial prefrontal cortex and basolateral region of the amygdala (BLA), and male neuritin knockout mice exhibited depressive and anxiety-like behaviors. We also observed that the expression of Neuritin was decreased by unpredictable chronic stress (UCS) in the male mouse brain and that decreased expression of neuritin was associated with reduced axonal branching of serotonin neurons in the brain and with depressive and anxiety behaviors in mice. Furthermore, the stress-mediated impairments in axonal branching and depressive behaviors were reversed by the overexpression of Neuritin in the BLA. The ability of neuritin to increase axonal branching in serotonin neurons involves FGF signaling, and neuritin contributes to FGF-2-mediated axonal branching regulation in vitro Finally, the oral administration of an FGF inhibitor reduced the axonal branching of serotonin neurons in the brain and caused depressive and anxiety behaviors in male mice. Our results support the involvement of neuritin in models of stress-induced depression and suggest that neuronal morphological plasticity may play a role in controlling animal behavior.Significance statement Axonal atrophy of serotonin neurons is one of the representative neuroanatomical features of depression. We found that the secreted/membrane-anchored neurotrophic factor Neuritin regulated axonal branch formation, which is involved in the development of depression and anxiety. In addition, Neuritin and the secreted signaling protein fibroblast growth factor 2 (FGF-2) cooperate to promote axonal branching in serotonin neurons. Furthermore, the inhibition of FGF signaling promoted axonal branching impairments and depressive behavior in mice. Taken together, these findings suggest that Neuritin regulates axonal branching in serotonin neurons and that the loss of neuritin is related to the development of depression. FGF signaling is involved in the neuritin-mediated axonal branching of serotonin neurons.

Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Study on Mechanism of Neurotrophin 3 in Depression Induced by Chronic Stress

Neurotrophins and depression

New Insights into BDNF Function in Depression and Anxiety

F14. Characterizing Neurotrophic Systems in the Primate Amygdala That Are Relevant to Mediating and Treating Anxiety Disorders

MiR-184-3p in the paraventricular nucleus participates in the neurobiology of depression via regulation of the hypothalamus-pituitary-adrenal axis

Role of 5-hydroxytryptamine type 3 receptors in the regulation of anxiety reactions

PI3K/Akt Signaling Pathway in the Basolateral Amygdala Mediates the Rapid Antidepressant-like Effects of Trefoil Factor 3

Brain-Derived Neurotrophic Factor Precursor in the Hippocampus Regulates Both Depressive and Anxiety-Like Behaviors in Rats.

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

Neuropeptide Trefoil Factor 3 Reverses Depressive-Like Behaviors by Activation of BDNF-ERK-CREB Signaling in Olfactory Bulbectomized Rats

Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity

A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists

Disfunction of dorsal raphe nucleus-hippocampus serotonergic-HTR3 transmission results in anxiety phenotype of Neuroplastin 65-deficient mice

Role of BDNF in the pathophysiology and treatment of depression: Activity‐dependent effects distinguish rapid‐acting antidepressants

The NLRP3 inflammasome in depression: Potential mechanisms and therapies

Neuroimmune Crosstalk Through Brain-Derived Neurotrophic Factor and Its Precursor Pro-Bdnf: New Insights into Mood Disorders

Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

Prefrontal TNRC6A mediates anxiety-like behaviour by regulating CRF through the maintenance of miR-21-3p stability

Neuritin controls axonal branching in serotonin neurons: A possible mediator involved in the regulation of depressive and anxiety behaviors via FGF signaling